SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026

ConferenceAutomated Insulin Delivery SystemPositive

AI Analysis

Summary

SiBionics and PharmaSens presented their automated insulin delivery technology at EASD 2026, showcasing a vision for advanced diabetes care combining continuous sensing with future treatment approaches.

Importance:3/10

Sentiment:

0.30

diabetescontinuous glucose monitoringinsulin deliverymedical devicesconference presentation

Related Companies

$GLUC $FVNNR

Read the original article

Published by PR Newswire Biotech on October 4, 2026 3:09 AM

Read Original